Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulation of prostasin by aldosterone in the kidney
Takefumi Narikiyo, Kenichiro Kitamura, Masataka Adachi, Taku Miyoshi, Kozo Iwashita, Naoki Shiraishi, Hiroshi Nonoguchi, Li-Mei Chen, Karl X. Chai, Julie Chao, Kimio Tomita
Takefumi Narikiyo, Kenichiro Kitamura, Masataka Adachi, Taku Miyoshi, Kozo Iwashita, Naoki Shiraishi, Hiroshi Nonoguchi, Li-Mei Chen, Karl X. Chai, Julie Chao, Kimio Tomita
View: Text | PDF
Article

Regulation of prostasin by aldosterone in the kidney

  • Text
  • PDF
Abstract

Prostasin is a serine protease present in mammalian urine that increases the activity of the epithelial sodium channel (ENaC) when the two are coexpressed in Xenopus oocytes. To determine if aldosterone, one of the principal regulators of urinary Na reabsorption by the distal nephron, affects prostasin expression, we examined prostasin mRNA and protein in a cultured mouse cortical collecting duct cell line (M-1), whole rats, and patients with primary aldosteronism. Aldosterone treatment of M-1 cells substantially increased prostasin expression and stimulated 22Na uptake. Urinary excretion of prostasin in rats that were infused with aldosterone likwise increased by ∼4-fold when compared with the vehicle-infused rats. Finally, urinary excretion of prostasin in patients with primary aldosteronism was substantially increased when compared with normal patients. Adrenalectomy reduced urinary prostasin excretion to control levels, whereas urinary prostasin levels were not altered in patients undergoing surgery for other reasons. In patients with primary aldosteronism, reduction in the urinary excretion of prostasin correlated with the increase in the urinary Na/K ratio. These findings, together with our previous report that prostasin activates the amiloride-sensitive Na currents through ENaC, demonstrate that prostasin regulates Na balance in vivo by virtue of its heightened expression in the presence of aldosterone.

Authors

Takefumi Narikiyo, Kenichiro Kitamura, Masataka Adachi, Taku Miyoshi, Kozo Iwashita, Naoki Shiraishi, Hiroshi Nonoguchi, Li-Mei Chen, Karl X. Chai, Julie Chao, Kimio Tomita

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Effect of amiloride on aldosterone-induced expression of prostasin prote...
Effect of amiloride on aldosterone-induced expression of prostasin protein in M-1 cells. M-1 cells were treated with 1 μM aldosterone or vehicle in the presence or absence of 5 μM amiloride for 24 hours. Prostasin protein abundance was determined by immunoblotting. Treatment of M-1 cells with amiloride had no effect on the secretion of prostasin in the culture media (aldosterone: 1.9-fold ± 0.2-fold, aldosterone + amiloride: 1.8-fold ± 0.7-fold, not significant). This figure is representative of four separate experiments. Am, amiloride. Values are mean ± SEM (n = 4). NS, not significant; *P < 0.02.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts